Primary hyperaldosteronism overview: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) m Usama Talib moved page Conn syndrome overview to Primary hyperaldosteronism overview without leaving a redirect |
Usama Talib (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Primary hyperaldosteronism}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Revision as of 15:06, 10 July 2017
|
Primary hyperaldosteronism Microchapters |
|
Differentiating Primary Hyperaldosteronism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary hyperaldosteronism overview On the Web |
|
American Roentgen Ray Society Images of Primary hyperaldosteronism overview |
|
Risk calculators and risk factors for Primary hyperaldosteronism overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Conn's syndrome' is characterized by the overproduction of the mineralocorticoid hormone aldosterone by the adrenal glands. Aldosterone causes sodium and water retention and potassium excretion in the kidneys, leading to arterial hypertension (high blood pressure). It is a rare but recognised cause of hypertension.
